David M Rapoport, MD
img_David M Rapoport
PROFESSOR | Medicine, Pulmonary, Critical Care and Sleep Medicine
Are you a patient?
Pulmonary Medicine (Lung), Sleep Medicine, Internal Medicine
Aging, Alzheimer's Disease, Brain, Brain Imaging, Imaging, Mathematical Modeling of Biomedical Systems, Mathematical and Computational Biology, Memory, Neural Networks, Neurobiology, Neuromuscular System, Neurophysiology, Neuroscience, Respiratory Tract, Systems Biology, Systems Neuroscience

MD, Yeshiva University Albert Einstein College of Medicine

Residency, Internal Medicine, St. Luke's-Roosevelt Hospital Center

Fellowship, Pulmonary Disease, NYU Medical Center


American Board of Internal Medicine
How 40 Years of Studying Obstructive Sleep Apnea Has Awoken Medicine to Sleep

Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device and biotechnology companies to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their relationships with such companies.

Below are financial relationships with industry reported by Dr. Rapoport during 2022 and/or 2023. Please note that this information may differ from information posted on corporate sites due to timing or classification differences.

Company Founder:

  • Foundation for Research in Sleep Disorders


  • Fisher and Paykel Healthcare

Royalty Payments:

  • Fisher and Paykel Healthcare

Scientific Advisory Board:

  • Foundation for Research in Sleep Disorders

Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website. Patients may wish to ask their physician about the activities they perform for companies.